Showing results (371-380 of 409) with videos related to

Sort By:
Pageof 41
Oncology Nursing Forum|January 10, 2017
2016 Updated American Society of Clinical Oncology/Oncology Nursing Society Chemotherapy Administration Safety Standards, Including Standards for Pediatric OncologyMichael Neuss, Terry Gilmore, Kristin Belderson, et al.
Cardiovascular and Interventional Radiology|April 27, 2026
Effectiveness and Safety of Bleomycin Electrosclerotherapy for Slow-Flow Vascular Malformations: A Systematic ReviewJohannes Gehr, Louise Hindsø, Mikkel Taudorf, et al.
Nanotoxicology|January 15, 2011
Biomedical nanoparticles modulate specific CD4+ T cell stimulation by inhibition of antigen processing in dendritic cellsFabian Blank, Peter Gerber, Barbara Rothen-Rutishauser, et al.
Proceedings. Biological Sciences|March 15, 2021
Sex differences in condition dependence of natal dispersal in a large herbivore: dispersal propensity and distance are decoupledA J M Hewison, J-M Gaillard, N Morellet, et al.
The Journal of Animal Ecology|October 3, 2025
Synching with seasonality: Predicting roe deer parturition phenology across its distributional rangeJohanna Kauffert, A J Mark Hewison, Benedikt Gehr, et al.
BMJ Open|February 9, 2021
Improvement of transitional care from hospital to home for older patients, the TIGER study: protocol of a randomised controlled trialMartina Rimmele, Jenny Wirth, Sabine Britting, et al.
American Journal of Hematology|December 22, 2017
A phase I/II trial of vorinostat (SAHA) in combination with rituximab-CHOP in patients with newly diagnosed advanced stage diffuse large B-cell lymphoma (DLBCL): SWOG S0806Daniel O Persky, Hongli Li, Lisa M Rimsza, et al.
Kidney International|September 29, 2001
Vancomycin-resistant enterococci colonization in patients at seven hemodialysis centersJ I Tokars, T Gehr, W R Jarvis, et al.
The Journal of Animal Ecology|December 5, 2019
Fear of the dark? Contrasting impacts of humans versus lynx on diel activity of roe deer across EuropeNadège C Bonnot, Ophélie Couriot, Anne Berger, et al.
Clinical Transplantation|October 10, 2002
Calcineurin inhibitor-induced chronic nephrotoxicity in liver transplant patients is reversible using rapamycin as the primary immunosuppressive agentAdrian H Cotterell, Robert A Fisher, Anne L King, et al.
Pageof 41